Caribou Biosciences, Inc. (CRBU)
0.4487
+0.04
(+8.83%)
USD |
NASDAQ |
Nov 06, 16:00
0.4423
-0.01
(-1.43%)
After-Hours: 20:00
Caribou Biosciences Shareholders Equity (Quarterly) : 76.63M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 76.63M |
| June 30, 2026 | 98.10M |
| March 31, 2026 | 102.02M |
| December 31, 2025 | 122.18M |
| September 30, 2025 | 141.84M |
| June 30, 2025 | 166.13M |
| March 31, 2025 | 217.22M |
| December 31, 2024 | 252.95M |
| September 30, 2024 | 281.20M |
| June 30, 2024 | 310.46M |
| March 31, 2024 | 343.29M |
| December 31, 2023 | 368.40M |
| Date | Value |
|---|---|
| September 30, 2023 | 398.27M |
| June 30, 2023 | 269.46M |
| March 31, 2023 | 278.27M |
| December 31, 2022 | 300.87M |
| September 30, 2022 | 324.11M |
| June 30, 2022 | 347.89M |
| March 31, 2022 | 371.80M |
| December 31, 2021 | 387.82M |
| September 30, 2021 | 404.40M |
| June 30, 2021 | -47.69M |
| March 31, 2021 | -35.69M |
| December 31, 2020 | -23.44M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 112.45M |
| Vaxcyte, Inc. | 2.489B |
| Foghorn Therapeutics, Inc. | -81.04M |
| Bolt Biotherapeutics, Inc. | 12.64M |
| Connect Biopharma Holdings Ltd. | 26.86M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 123.03M |
| Total Liabilities (Quarterly) | 46.39M |
| Debt to Equity Ratio | 0.3437 |
| Current Ratio | 4.968 |
| Net Debt Paydown Yield | -0.07% |